Melatonin Mitigates Cisplatin-Induced Ovarian Dysfunction via Altering Steroidogenesis, Inflammation, Apoptosis, Oxidative Stress, and PTEN/PI3K/Akt/mTOR/AMPK Signaling Pathway in Female Rats

Ovarian damage and fertility impairment are major side effects of chemotherapy in pre-menopausal cancer patients. Cisplatin is a widely used chemotherapeutic drug. The present study was designed to assess the ameliorative effects of melatonin as an adjuvant for fertility preservation. Thirty-two adu...

Full description

Saved in:
Bibliographic Details
Main Authors: Amal Al-Shahat (Author), Mohey A. E. Hulail (Author), Nada M. M. Soliman (Author), Tarek Khamis (Author), Liana Mihaela Fericean (Author), Ahmed Hamed Arisha (Author), Rania S. Moawad (Author)
Format: Book
Published: MDPI AG, 2022-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_2eef65e0cb5646b5be06c653241b3ade
042 |a dc 
100 1 0 |a Amal Al-Shahat  |e author 
700 1 0 |a Mohey A. E. Hulail  |e author 
700 1 0 |a Nada M. M. Soliman  |e author 
700 1 0 |a Tarek Khamis  |e author 
700 1 0 |a Liana Mihaela Fericean  |e author 
700 1 0 |a Ahmed Hamed Arisha  |e author 
700 1 0 |a Rania S. Moawad  |e author 
245 0 0 |a Melatonin Mitigates Cisplatin-Induced Ovarian Dysfunction via Altering Steroidogenesis, Inflammation, Apoptosis, Oxidative Stress, and PTEN/PI3K/Akt/mTOR/AMPK Signaling Pathway in Female Rats 
260 |b MDPI AG,   |c 2022-12-01T00:00:00Z. 
500 |a 10.3390/pharmaceutics14122769 
500 |a 1999-4923 
520 |a Ovarian damage and fertility impairment are major side effects of chemotherapy in pre-menopausal cancer patients. Cisplatin is a widely used chemotherapeutic drug. The present study was designed to assess the ameliorative effects of melatonin as an adjuvant for fertility preservation. Thirty-two adult female Wistar rats were divided randomly into four equal groups: Control, Melatonin, Cisplatin (CP) treated, and CP + Melatonin treated. The cisplatin-treated group showed decreased body and ovarian weights, decreased serum E2 and AMH, increased serum LH and FSH, reduced ovarian levels of SOD, CAT, GSH, and TAC, and increased ovarian MDA. The histopathological examination of the cisplatin-treated group showed deleterious changes within ovarian tissue in the form of damaged follicles and corpus luteum, hemorrhage, and inflammatory infiltrates with faint PAS reaction in zona pellucida, increased ovarian collagen deposition, and marked expression of caspase-3 immune reaction in granulosa and theca cells, stroma, and oocytes. Alongside, there was a significant downregulation in the mRNA expression of steroidogenic enzymes, IL10, AMPK, PI3K, AKT, mTOR, and PTEN, while TGF-β1, IL1β, IL6, TNF-α, NF-Kβ, P53, p38-MAPK, JNK, and FOXO3 mRNA expressions were upregulated in cisplatin-treated rats' ovarian tissue. Coadministration of cisplatin-treated rats with melatonin reversed these changes significantly. In conclusion, melatonin's antioxidant, anti-inflammatory, and anti-apoptotic activities could modulate ovarian disturbances induced by cisplatin and preserve fertility. 
546 |a EN 
690 |a cisplatin 
690 |a melatonin 
690 |a ovary 
690 |a steroidogenesis 
690 |a oxidative stress 
690 |a ovarian impairment 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceutics, Vol 14, Iss 12, p 2769 (2022) 
787 0 |n https://www.mdpi.com/1999-4923/14/12/2769 
787 0 |n https://doaj.org/toc/1999-4923 
856 4 1 |u https://doaj.org/article/2eef65e0cb5646b5be06c653241b3ade  |z Connect to this object online.